Klaus Strömer
YOU?
Author Swipe
View article: Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021
Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021 Open
Background In recent years, legal and infrastructural conditions have been set to improve the adoption of digital applications in health care in Germany. The impact of these actions was amplified by the COVID-19 pandemic. So far, no studie…
View article: Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021 (Preprint)
Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021 (Preprint) Open
BACKGROUND In recent years, legal and infrastructural conditions have been set to improve the adoption of digital applications in health care in Germany. The impact of these actions was amplified by the COVID-19 pandemic. So far, no studi…
View article: German S1 guideline: Contact dermatitis
German S1 guideline: Contact dermatitis Open
Summary Contact dermatitis is an inflammation of the epidermis and dermis at the site of exposure triggered by external agents. The two main forms are irritant and allergic contact dermatitis, which cause significant health and socioeconom…
View article: Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Guideline on allergen immunotherapy in IgE-mediated allergic diseases Open
Not available.
View article: Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs
Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs Open
Summary Background In Germany, skin diseases are mainly treated in the 115 dermatological hospitals. Methods Health care and health economic analysis of dermatological inpatient care and prediction of future care needs based on primary and…
View article: Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004‐2017
Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004‐2017 Open
Background In the study series PsoHealth first data from 2004/05 showed a poor quality of health care for psoriasis in Germany. Most patients lacked sufficient care and only a minor proportion received systemic drugs. Since 2007, a nationa…
View article: EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations Open
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specif…
View article: EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations Open
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The first part of the guideline includes general information …
View article: Biosimilars in Dermatology – theory becomes reality
Biosimilars in Dermatology – theory becomes reality Open
Summary Biosimilars are biological medicines that are analogues of a specific reference product. Biosimilars of the tumor necrosis factor alpha inhibitors infliximab and etanercept are already approved and available for dermatological indi…
View article: Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression
Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression Open
Background Non‐melanoma skin cancer ( NMSC ) and actinic keratosis ( AK ) are very common among fair‐skinned individuals. A disease continuum from AK to squamous cell carcinoma ( SCC ) has been frequently postulated. AK and NMSC may influe…
View article: The German National Program on Psoriasis Health Care 2005–2015: results and experiences
The German National Program on Psoriasis Health Care 2005–2015: results and experiences Open
In 2005, the first national psoriasis survey in Germany revealed large deficits in health care particularly in patients with moderate to severe disease. The consecutive goal was to improve health care for psoriasis countrywide. For this, a…
View article: Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria
Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria Open
Summary Chronic spontaneous urticaria (CSU) is a common and challenging disease, especially with respect to healthcare provision in the context of the German statutory health insurance system. If treatment with second‐generation antihistam…